BioInvent International AB (BINV) — Capital Reinvestment Ratio

Latest as of June 2025: 0.02x

BioInvent International AB (BINV) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow (Skr66.78 Million) in capital expenditures (Skr1.38 Million). See net asset quality index of BioInvent International AB to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

Skr66.78 Million
SEK

Capital Expenditures

Skr1.38 Million
SEK

Data as of

Jun 2025
Most recent filing

BioInvent International AB Capital Reinvestment Ratio (2007–2008)

This chart tracks BioInvent International AB's Capital Reinvestment Ratio across 2 annual periods. Check how aggressively does BioInvent International AB reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for BioInvent International AB (2007–2008)

Year-by-year Capital Reinvestment Ratio for BioInvent International AB from 2007 to 2008. For live market cap and broader valuation context, see BINV company net worth.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2008 0.31x Skr43.73 Million Skr13.64 Million ▲ +0.8%
2007 0.31x Skr12.63 Million Skr3.91 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow